Mainz Biomed N.V. (MYNZ) concluded trading on Thursday at a closing price of $0.28, with 2.64 million shares of worth about $0.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.54% during that period and on October 24, 2024 the price saw a loss of about -4.10%. Currently the company’s common shares owned by public are about 21.17M shares, out of which, 17.46M shares are available for trading.
Stock saw a price change of -6.68% in past 5 days and over the past one month there was a price change of 36.86%. Year-to-date (YTD), MYNZ shares are showing a performance of -76.03% which decreased to -87.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $3.39 during that period. The average intraday trading volume for Mainz Biomed N.V. shares is 1.98 million. The stock is currently trading -3.81% below its 20-day simple moving average (SMA20), while that difference is down -9.32% for SMA50 and it goes to -57.48% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V. (NASDAQ: MYNZ) currently have 21.17M outstanding shares and institutions hold larger chunk of about 0.56% of that.
The stock has a current market capitalization of $6.09M and its 3Y-monthly beta is at 0.08. It has posted earnings per share of -$1.64 in the same period. It has Quick Ratio of 0.91 while making debt-to-equity ratio of 1.96. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MYNZ, volatility over the week remained 13.06% while standing at 16.57% over the month.
Coverage by H.C. Wainwright stated Mainz Biomed N.V. (MYNZ) stock as a Buy in their note to investors on June 21, 2022, suggesting a price target of $25 for the stock.
